In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Presence of an Aneurysm Serves as a Predictor of Hemorrhagic Presentation in Patients with Cerebral AVMs

    Final Number:
    1030

    Authors:
    Thana N. Theofanis MD; Brendan Judy; Nohra Chalouhi MD; Pascal Jabbour MD; Robert H. Rosenwasser MD, FACS, FAHA; Stavropoula I. Tjoumakaris MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: Cerebral AVMs are found in 0.1% of the population. When they occur, they are often found in young, healthy individuals, and hemorrhage can be a source of unnecessary morbidity and mortality in these otherwise healthy patients. Identifying risk factors of hemorrhage could help guide decisions to treat AVMs.

    Methods: A retrospective review of all patients treated for AVMs at the Jefferson Hospital for Neuroscience between 1994 and 2010. Data were collected on patient co-morbidities, presence of aneurysm, characteristics of the aneurysm, Spetzler-Martin (SM) Grade of the AVM, clinical presentation, treatment(s) received, therapeutic and clinical outcomes, as well as any complications.

    Results: Of 774 AVM patients treated at the Jefferson Hospital for Neuroscience from 1994-2010, 7.5% (N=61) of the patients were found to have angiographically documented aneurysms. According to the Redekopp et al., classification: 16.4% (N=10) of the aneurysms were intranidal, 52.5% (N=32) were flow related, and 31.1% (N=19) were flow unrelated. According to the Cunha et al., classification 23% (N=14) aneurysms were Grade I, 4.9% (N=3) were Grade Ia, 19.7% (N=12) were Grade II, 21.3% (N=13) were Grade III, 31.1% (N=19) were Grade IV. Predictors of AVM hemorrhagic presentation in univariate analysis (p<0.20) include: presence of an aneurysm, age > 65, increasing number of aneurysms, hypertension, Redekop Grade 2 aneurysm, and Cunha Classification I, II, or III aneurysm.

    Conclusions: The outcomes of AVM patients who present with a hemorrhage can be devastating. In patients with concurrent vascular pathologies, such as an AVM and aneurysm(s), referral to a high-volume neurovascular treatment center for treatment should be strongly considered, as these patients are at a higher risk of experiencing hemorrhagic presentation.

    Patient Care: Identifying risk factors of hemorrhage could help guide decisions to treat AVMs.

    Learning Objectives: 1. Understand the natural history of patient's with AVMs, as well as AVM and aneurysms 2. Identify risk factors for hemorrhage in patients with AVMs

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy